Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner.
about
Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Lysophosphatidylcholine and it ...... ceptors in a different manner.
@en
Lysophosphatidylcholine and it ...... ceptors in a different manner.
@nl
type
label
Lysophosphatidylcholine and it ...... ceptors in a different manner.
@en
Lysophosphatidylcholine and it ...... ceptors in a different manner.
@nl
prefLabel
Lysophosphatidylcholine and it ...... ceptors in a different manner.
@en
Lysophosphatidylcholine and it ...... ceptors in a different manner.
@nl
P2093
P1476
Lysophosphatidylcholine and it ...... eceptors in a different manner
@en
P2093
Anna Drzazga
Edyta Gendaszewska-Darmach
Hjalti Kristinsson
Maciej Sałaga
Maria Koziołkiewicz
Peter Bergsten
P304
P356
10.1016/J.MCE.2017.12.002
P50
P577
2017-12-08T00:00:00Z